Indonesia SEZ for Medical Device Manufacturing in 2026: Is It the Best Base in Southeast Asia?

介绍

The global healthcare supply chain is undergoing a significant shift. For foreign medical device manufacturers, distributors, and healthcare companies looking to expand in Southeast Asia, finding the right production and distribution base has never been more strategic. 

In 2026, Indonesia SEZ for medical device manufacturing is emerging as a serious option, not just because of tax incentives, but because of its raw material advantages, growing middle-class healthcare demand, and improving regulatory framework. Yet Vietnam, Malaysia, and Thailand each offer compelling alternatives.

This guide breaks down the key differences across all four countries, helping international healthcare businesses make informed decisions about where to set up operations, secure a business license, and build a sustainable manufacturing presence in ASEAN.

Quick Comparison Table (2026 Data)

特征	印度尼西亚	越南	马来西亚	泰国
Primary Strength	Downstream resources + domestic demand	Electronics and export volume	Semiconductor and high-tech R&D	Automotive and smart technology
Labor Cost	Competitive	Lowest	Higher (skilled)	缓和
Infrastructure	Rapidly improving	Good (Northern Hubs)	Excellent	High-tier (EEC)
Market Size	278 million (domestic)	100 million (export-led)	34 million (regional hub)	71 million (industrial base)
Key SEZ	Galang Batang, Sei Mangkei	Bac Ninh, Hai Phong	Johor-Singapore SEZ	Eastern Economic Corridor
Medical Device Appeal	High domestic demand + materials	Export efficiency	Precision tech components	Established supply chains

1. Indonesia SEZ for Medical Device Manufacturing: The Resource and Market Powerhouse

Indonesia is pursuing a long-game strategy that stands apart from its neighbors. Rather than positioning itself as an assembly-line economy, the Indonesian government is pushing aggressively toward downstream processing, which is where medical device manufacturers and healthcare supply chain companies will find a particularly interesting set of opportunities.

Raw Material Advantages for Healthcare Manufacturers

Indonesia controls more than 60 percent of global nickel production, a material that plays a direct role in battery components used in medical equipment and devices. For manufacturers producing diagnostic machines, portable medical devices, or next-generation healthcare wearables, proximity to this raw material supply is a significant operational advantage. Being based inside a Special Economic Zone (SEZ) like Galang Batang or Sei Mangkei is not simply about tax breaks; it is about being strategically close to the upstream supply chain that feeds modern medical device production.

Domestic Healthcare Demand as a Built-In Market

With a population of 278 million people, Indonesia presents a domestic healthcare market that few countries in Southeast Asia can match. For medical device companies and healthcare distributors, this scale matters. As Indonesia’s middle class continues to grow, demand for imported and locally manufactured medical equipment, diagnostics, and consumables is rising steadily. Unlike export-dependent markets, Indonesia’s sheer size means that even if global trade slows, the local market provides a meaningful buffer for businesses operating inside its borders.

Business Setup in Indonesia SEZ: Improving, but Requires Local Knowledge

The government has made significant strides in streamlining the business setup process through its OSS (Online Single Submission) system, which acts as a centralized digital gateway for licensing and regulatory approvals. For foreign healthcare companies, this means that securing a business license in Indonesia is becoming faster and more transparent than it was five years ago. However, navigating 业务流程对象模型 (the National Agency of Drug and Food Control) requirements for medical device registration still requires experienced local guidance, which is why working with a market entry specialist is strongly recommended.

Infrastructure Catching Up

The completion of the Trans-Java Toll Road and the expansion of Patimban Port have meaningfully reduced the logistics bottleneck that once made Indonesia less appealing to manufacturers. For medical device businesses moving time-sensitive inventory, these improvements matter. That said, inter-island logistics costs remain higher than in Thailand or Vietnam, and this is a factor that requires careful planning during the business setup phase.

2. Indonesia SEZ for Medical Device Manufacturing vs. Vietnam: Who Wins on Export Speed?

Vietnam has earned its reputation as a high-volume manufacturing hub, particularly for electronics and precision goods. In early 2026, foreign direct investment into Vietnam grew by nearly 9 percent, with 74 percent of that capital directed at manufacturing sectors.

For medical device companies whose primary goal is exporting finished goods to the United States or European markets, Vietnam holds a structural advantage. Its proximity to China enables seamless just-in-time supply chains for components, while trade agreements such as the EVFTA (EU-Vietnam Free Trade Agreement) and the CPTPP offer preferential tariff access to major Western markets.

However, Indonesia is narrowing this gap. The government’s extended corporate tax holidays, which can reach up to 20 years for “pioneer” industries (including health-related manufacturing), and the OSS licensing system are making Indonesia SEZ for medical device manufacturing increasingly competitive on a total-cost basis. For healthcare companies that want both export capacity and access to a massive domestic market, Indonesia offers a combination that Vietnam cannot replicate.

3. Business Setup in Indonesia SEZ vs. Malaysia: The Semiconductor and Precision Device Question

Malaysia’s Johor-Singapore Special Economic Zone (JS-SEZ) is arguably the most sophisticated high-tech manufacturing corridor in Southeast Asia in 2026. It is primarily focused on semiconductor design, chip packaging, and high-precision electronics. For medical device manufacturers who rely on advanced sensor technology, microprocessors, or integrated circuit components, Malaysia’s ecosystem is exceptionally well-developed.

The interesting dynamic emerging in this region is what industry observers call the “Twin Hub” model. Many international healthcare companies are choosing to conduct R&D, quality control, and component design in Malaysia or Singapore, while outsourcing high-volume assembly to nearby Batam, Indonesia, just a short ferry ride away. This arrangement balances the technical sophistication of Malaysia with the lower operational costs of an Indonesian SEZ.

For medical device manufacturers exploring business setup in this region, understanding the regulatory requirements in both countries, including Malaysia’s Medical Device Authority (MDA) and Indonesia’s BPOM, is essential to building a compliant and efficient cross-border operation.

4. Indonesia SEZ for Medical Device Manufacturing vs. Thailand: Two Very Different Strengths

Thailand’s Eastern Economic Corridor (EEC) remains a dominant force in Southeast Asian manufacturing, particularly for automotive and smart technology sectors. In 2025, Thailand attracted a record USD 42 billion in foreign direct investment applications, underscoring its appeal to large-scale industrial operators.

For medical device companies, Thailand offers a mature and well-connected supply chain ecosystem, particularly for electromechanical components used in medical equipment assembly. Its workforce is experienced in precision manufacturing, and the EEC provides strong infrastructure and regulatory clarity for foreign investors.

However, the comparison shifts when the discussion moves to next-generation healthcare products. If a manufacturer’s focus is on lithium battery-powered medical devices, portable diagnostics, or anything that depends on battery cell chemistry and raw mineral supply, Indonesia’s resource base gives it a more attractive long-term outlook through 2026 and beyond. For traditional medical equipment assembly with established component sourcing, Thailand remains a strong contender.

5. Indonesia’s Weak Spots for Medical Device Manufacturers: The Honest Assessment

A thorough market entry strategy requires acknowledging the challenges, not just the opportunities.

Logistics Costs Across an Archipelago

Indonesia’s geography presents unique challenges. At approximately 12 percent of GDP, logistics costs remain significantly higher than in Thailand or Vietnam. For medical device companies managing cold-chain logistics, time-sensitive distribution, or multi-island delivery networks, this is a real operational cost that must be factored into any financial model. The government has targeted a reduction to 8 percent of GDP by 2035, but that goal remains in the future.

Business License Complexity at the Local Level

While SEZs offer a streamlined one-stop service for business setup and business license applications, regulatory consistency can still vary at the regional government level outside SEZ boundaries. Foreign companies entering Indonesia for the first time are advised to work within designated SEZs and partner with local legal and regulatory experts to ensure full compliance with both national and local requirements.

BPOM Medical Device Registration

For healthcare-specific businesses, registering products with BPOM adds a layer of regulatory complexity that is not present in all competing markets. Medical devices must obtain a distribution permit (izin edar) before they can be legally sold or used in Indonesia. This process can take anywhere from a few months to over a year, depending on the device classification. A proactive market entry strategy should account for this timeline from the outset.

Conclusion: Which Country Is Right for Your Medical Device Business?

Choosing the right base for Indonesia SEZ for medical device manufacturing in 2026 ultimately depends on the nature of the product, target markets, and long-term strategic goals.

Choose Indonesia if: The focus is on serving the domestic Indonesian and broader ASEAN healthcare market, accessing raw material supply chains for battery-powered or next-gen medical devices, or establishing a manufacturing operation with long-term tax incentives and a large end-customer base.

Choose Vietnam if: The priority is high-volume production for export to the US or EU, with a supply chain that relies heavily on Chinese components and fast turnaround.

Choose Malaysia if: The product line involves advanced semiconductor-based medical devices, precision diagnostics, or high-tier automated manufacturing that requires a sophisticated technical workforce.

Choose Thailand if: The business is focused on electromechanical medical equipment with established component sourcing and benefits from the EEC’s mature industrial ecosystem.

For many international healthcare companies, Indonesia SEZ for medical device manufacturing represents the most compelling combination of market size, resource access, and improving regulatory infrastructure. But entering this market without the right local expertise, particularly around business license applications and BPOM compliance, significantly increases the risk of costly delays.

Ready to explore your options in Indonesia or across ASEAN? Speak with a market entry specialist to receive a custom feasibility study tailored to your product category and business objectives.